首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   766篇
  免费   79篇
  国内免费   71篇
林业   3篇
农学   20篇
  8篇
综合类   212篇
农作物   3篇
水产渔业   169篇
畜牧兽医   500篇
植物保护   1篇
  2023年   11篇
  2022年   21篇
  2021年   25篇
  2020年   42篇
  2019年   42篇
  2018年   32篇
  2017年   24篇
  2016年   38篇
  2015年   44篇
  2014年   67篇
  2013年   64篇
  2012年   69篇
  2011年   62篇
  2010年   45篇
  2009年   65篇
  2008年   50篇
  2007年   54篇
  2006年   40篇
  2005年   35篇
  2004年   14篇
  2003年   12篇
  2002年   15篇
  2001年   9篇
  2000年   4篇
  1999年   7篇
  1998年   1篇
  1997年   1篇
  1996年   1篇
  1995年   3篇
  1994年   4篇
  1993年   1篇
  1992年   1篇
  1991年   1篇
  1990年   3篇
  1989年   2篇
  1988年   1篇
  1986年   2篇
  1978年   1篇
  1956年   3篇
排序方式: 共有916条查询结果,搜索用时 31 毫秒
1.
X Luo  G Liao  C Liu  X Jiang  M Lin  C Zhao  J Tao  Z Huang 《Journal of fish diseases》2018,41(10):1477-1484
Streptococcus agalactiae is a causative agent responsible for massive mortalities of tilapia that has led to catastrophic losses to tilapia culture globally. Bacteriophages represent a new class of antimicrobials against bacteria. In this study, we characterized the bacteriophage HN48, which formed small and round‐transparent plaques on a double‐layer plate. With a hexagonal head and a long tail, this phage may belong to the Caudovirales according to the International Committee on Taxonomy of Viruses. HN48 was found to have a relatively wide and highly specific host range, to be sensitive to high temperature (60–80°C) and low pH (3–5), and to be relatively stable at alkaline pH (8–10). Intraperitoneal injection with HN48 had no adverse effects on tilapia and effectively inactivated the bacteria in the kidney. Fish that received phage therapy had 60% ± 3.3% survival rates and a delayed mean death time of about 3 days when compared to the control group. To the best of knowledge, this is the first study of tilapia streptococcal phage. Overall, the results indicated that phage HN48 could prevent tilapia from experimental S. agalactiae infection, suggesting it has the potential to control this disease.  相似文献   
2.
为评价罗非鱼源无乳链球菌(Streptococcus agalactiae)BX2012株脂蛋白(lipoprotein)的免疫原性及其对奥利亚罗非鱼(Oreochromis aureus)和大菱鲆(Scophthalmus maximus)的保护效果,以无乳链球菌脂蛋白基因序列(GenBank序列号:CP000114.1,SAK_0321)的B细胞线性抗原表位区设计特异性引物进行扩增,构建重组表达载体,将截短表达的脂蛋白制备成亚单位疫苗,同时制备灭活疫苗进行免疫比对。结果显示:重组表达载体p ET-32a-LIP342在BL21(DE3)中获得了良好的可溶性表达,分子质量约为30 kDa,纯化使LIP342纯度由41.75%提至87.23%;Western blotting分析显示,LIP342可被兔抗无乳链球菌高免血清特异性识别;LIP342在目前已知不同种属来源或不同血清型的无乳链球菌分离株中同源性为90.35%~100%,在罗非鱼源分离株中同源性为100%;无乳链球菌LIP342蛋白和灭活疫苗均可显著提升奥利亚罗非鱼和大菱鲆血清抗体水平,而LIP342诱导的血清抗体水平均显著高于灭活疫苗;经0.1 mL 1×10~9cfu/mL的无乳链球菌攻毒后,LIP342蛋白和灭活疫苗对供试鱼的累积存活率均显著高于PBS对照组。结果表明,高度保守的LIP342具有较好的免疫原性,可作为无乳链球菌亚单位疫苗候选因子。  相似文献   
3.
The objective of this study was to evaluate the effect of dietary and water supplementation of probiotic Streptococcus phocae PI80 on growth, immune response and feed utilization of tiger shrimp Penaeus monodon in earthen ponds. The probiotic bacterium S. phocae PI80 was cultured in large fermenter (50 L) by adding additional carbon source in the form of molasses and glucose along with yeast extract as nitrogen source to enrich S. phocae PI80 biomass. This enriched S. phocae PI80 was administered to shrimp in feed (6.5 × 1013 bacterial cells mL?1) as well as in pond water (5 L/pond). Shrimp growth performance was significantly improved (P < 0.05) in 120 days culture when the average body weight of treated molasses + yeast extract (MY) (28.41 ± 0.874 g), glucose + yeast extract (GY) (27.013 ± 0.698 g) was significantly higher than control (23.63 ± 0.684 g). Food conversion ratio FCR was also found to be reduced significantly in ponds treated with probiotics when compared with control pond (1.89 ± 0.09). Vibrio and luminescent bacteria were found to be lower in the treatment receiving MY group, and we hypothesize that this may lead to greater shrimp survival. Furthermore, fermentation product of S. phocae PI80 added to pond water and feed additives enhanced the shrimp immune system. The results indicated that total haemocytes count (THC), phenoloxidase (PO) activity, NBT reductase assay and phagocytic activity significantly increased in shrimps treated with S. phocae PI80. Our study demonstrates that administration of S. phocae PI80 in the water and feed at 6.5 × 1013 colony‐forming units (CFU) mL?1 bacterial cells induce immune modulation and enhances the immune ability of P. monodon in pond‐reared shrimp and increased the shrimp production.  相似文献   
4.
Grass fructans can be fermented by Gram-positive bacteria (e.g., Streptococcus bovis) in the equine hindgut, increasing production of lactic acid and decreasing pH. The degree of polymerization (DP) of fructans has been suggested to influence fermentation rates. The objective of the present study was to determine how DP impacts fermentation by equine fecal bacteria and a model S. bovis. Fecal microbes from three mares were harvested by differential centrifugation, washed, and resuspended in anaerobic media containing short-chain (SC; DP ≤ 10) or long-chain (LC) inulin (DP ≥ 23) from 0% to 2% wt/vol. After 24 hours of incubation (37°C), samples were collected for pH determination. Data were analyzed using the general linear models (GLM) procedure testing for the effect of treatment, concentration, and treatment × concentration (SAS v. 9.3). At all concentrations, the pH was lower in SC fermentations than in LC (P < .0001, in all cases). To determine the effect of DP on S. bovis, cultures were grown (39°C, 9 hours) with 0.1%, 0.5%, or 1.3% SC or LC inulin. Optical density (600 nm) was determined by spectrophotometry. Maximum specific growth rates (μ) were determined by linear regression (2–5 hours). Data were analyzed using the one-way analysis of variance procedure (SAS v. 9.3). The final optical density (600 nm), μ, and yield were higher with SC than with LC fermentation (P < .05). These results indicate that SC inulin may be more available for fermentation than LC inulin by equine fecal bacteria and S. bovis, specifically.  相似文献   
5.
[目的]掌握河南省猪等孢球虫的分子变异规律。[方法]从河南省豫东、豫南、豫西、豫北及豫中地区的部分规模化猪场采集粪便样品,进行猪球虫卵囊的分离与纯化;从分离到的8株猪球虫分离株中提取核酸并进行测序,并与猪等孢球虫扩增株基因序列及其他相关原虫基因序列进行比对。[结果]河南省不同地区的8个猪球虫株均为猪等孢球虫,并且没有明显遗传差异。I.suis与其他7种原虫差异较大,不属于同一个生物型,同一种动物所感染的不同种类原虫之间的同源性较低。[结论]该研究结果可为有效预防和控制仔猪球虫病提供科学依据。  相似文献   
6.
猪支原体肺炎是生猪养殖中较为常见的一种猪肺疾病类型,该病具有高度接触性、慢性传染性等特点,如果未能得到及时有效的处理则会扩散至整个生猪群体范围,对生猪养殖的经济效益造成严重损害。且在猪支原体肺炎的发生中,该病经常与圆环病毒及其他病原体进行混合感染,进一步加深生猪病情,对生猪养殖造成非常严重的经济损失。养殖人员在生猪养殖中务必要加强对于猪支原体肺炎的重视程度,积极了解猪支原体肺炎的临床症状与发生特点,采取有效的防治措施以避免猪支原体肺炎发生。该文主要论述猪支原体肺炎的发生特点、临床症状以及诊断防治。  相似文献   
7.
Streptococcus spp. are major pathogenic bacteria associated with massive mortality in tilapia. This study investigated the phenotypic and genotypic characterization of Streptococcus agalactiae (GBS) and Streptococcus iniae (S. iniae) isolated from tilapia in river-based floating cage and earthen pond farms in northern Thailand. Isolates were identified by biochemical and molecular analyses. Capsular typing, enterobacterial repetitive intergenic consensus polymerase chain reaction and multilocus sequence typing were performed to investigate the genetic relatedness. Six and one isolates were confirmed as GBS and S. iniae, respectively. All Streptococcus spp. isolates were obtained from 4 river-based cage farms (4/33), while samples collected from earthen pond farms (N = 28) were negative for streptococcosis. All GBS with serotype Ⅲ and sequence type (ST) 283 was observed. The β-haemolytic GBS isolates were resistant to five antimicrobials, while the S. iniae was susceptible to all antimicrobials. This study indicates both GBS and S. iniae are the major bacterial pathogens responsible for streptococcosis infection in farmed tilapia of northern Thailand with GBS as dominant species. This survey highlights that the river-based cage farms seriously impact on the healthy development of the tilapia industry.  相似文献   
8.
Outbreaks of an infectious disease affecting cultured white sturgeon (Acipenser transmontanus) were investigated. Clinical signs included erratic swimming, arching of the back and mortality. Necropsy findings included poorly demarcated yellow to dark-red and friable lesions in the epaxial muscle, ulcerative skin lesions and haemorrhages in the swim bladder and coelomic wall. Histological evaluation revealed areas of necrotizing and heterophilic myositis with aggregates of bacterial cocci. The lumen of blood vessels in the dermis, under ulcerated areas, and in the posterior kidney, was occluded by fibrin thrombi. Aggregates of Gram-positive cocci were observed in the muscle lesions and within the fibrin thrombi in the dermis and kidney. Genetically homogeneous Streptococcus iniae strains were recovered from affected fish from different outbreaks. The isolates shared high degree of similarity at gene locus (gyrB) with previously characterized S. iniae from cultured fish in California, confirming the emergence of this particular strain of S. iniae in US aquaculture.  相似文献   
9.
为探究无乳链球菌LrrG(Leucine-rich repeat protein from GBS)和表面免疫原性蛋白Sip(surface immunogenic protein)串联表达的LrrG-Sip重组融合蛋白的免疫原性,该研究将原核表达的LrrG-Sip重组融合蛋白分别以0.5μg·g~(-1)(R1组)、1.0μg·g~(-1)(R2组)和1.5μg·g-1(R3组)每尾200μL腹腔注射免疫尼罗罗非鱼(Oreochromis niloticus),同时以Sip蛋白(S组)、LrrG蛋白(L组)以及PBS(P组)作为对照。2周后对所有免疫鱼体进行无乳链球菌(Streptococcus agalactiae)人工攻毒,攻毒剂量为其半致死浓度(LD_(50):4.0×108CFU·mL~(-1))。结果显示LrrG-Sip重组融合蛋白R1组对尼罗罗非鱼的相对免疫保护率最高,达89.14%;且免疫后第14和第28天,该组鱼体血清抗体OD_(450nm)值分别达0.63和0.64,均显著高于单一蛋白对照组(S和L组)和PBS组(P0.05);R1组鱼体血清过氧化物酶(POD)和碱性磷酸酶(AKP)活性在上述2个时间点也显著高于其他组(P0.05);但溶菌酶(LZM)和总超氧化物歧化酶(T-SOD)活性与其他组之间差异不显著(P0.05)。初步表明LrrG-Sip重组融合蛋白具有良好的免疫原性,其免疫原性明显优于单个蛋白,且能有效减少免疫剂量。  相似文献   
10.
本研究以腹腔注射无乳链球菌(Streptococcus agalactiae, WC1535菌株)后的尼罗罗非鱼(Oreochromis niloticus,GIFT strain)为研究对象,研究不同水温下无乳链球菌在尼罗罗非鱼体内的动态分布及消除规律。首先,分析25℃、29℃和33℃3个实验组罗非鱼的感染累积死亡率;其次,对3个实验组罗非鱼进行无乳链球菌的体外分离、培养和计数;然后,分析感染后不同实验组罗非鱼脑、肝脏、脾脏和肾脏组织中无乳链球菌的浓度。结果显示,随着水温的升高罗非鱼的累积死亡率也随之升高,25℃、29℃和33℃组的累积死亡率分别为6.67%、25.56%和78.90%。菌落统计结果显示,随着水温的升高,无乳链球菌在罗非鱼体内的增殖速度加快,同时,单位质量组织(脑、肝脏、脾脏和肾脏)中无乳链球菌的最大载菌量也随之升高。本研究还发现,无乳链球菌在罗非鱼脾脏中的浓度最高,在肾脏中的存活时间最长。综上可知,尼罗罗非鱼感染无乳链球菌后,体内各组织中链球菌的增殖、消除速度均与水温密切相关。本研究为研究无乳链球菌的致病机制奠定基础,也为通过合理调控水温及施药等措施防治尼罗罗非鱼链球菌病的暴发提供科学依据。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号